StemCell InstituteTSE:7096 +0.92%69 OCF Margin % is 2.85% as of Mar. 2026, which is 84% below its 10-year median of 17.46. GuruFocus rates TSE:7096 with a GF Score™ of 69/100 and a GF Value™ of 円1,813.29 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 950 Biotechnology companies, StemCell Institute ranks better than 70.74% on this metric.
The historical rank and industry rank for StemCell Institute's OCF Margin % or its related term are showing as below:
TSE:7096'
s OCF Margin % Range Over the Past 10 Years
Min: 2.61 Med: 17.46 Max: 39.84
Current: 2.61
During the past 9 years, the highest OCF Margin % of StemCell Institute was 39.84%. The lowest was 2.61%. And the median was 17.46%.
TSE:7096's OCF Margin % is ranked better than 70.74% of 950
companies
in the Biotechnology industry
Industry Median: -65.71
vs TSE:7096: 2.61
StemCell Institute OCF Margin % Related Terms
StemCell Institute OCF Margin % Historical Data
* Premium members only.
The historical data trend for StemCell Institute's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7096 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, StemCell Institute's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
StemCell Institute OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, StemCell Institute's OCF Margin % distribution charts can be found below:
* The bar in red indicates where StemCell Institute's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
StemCell Institute (TSE:7096) has a OCF Margin % of 2.85% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on StemCell Institute and its competitors. This is 84% below median its historical median of 17.46. Over the past decade, StemCell Institute's OCF Margin % has ranged from 2.61 to 39.84. According to the industry distribution chart, StemCell Institute ranks #278 out of 950 companies in the Biotechnology industry, placing it in the top 29.3%.
Is StemCell Institute's OCF Margin % too high?
StemCell Institute's current OCF Margin % of 2.85% is 84% below median its 10-year median of 17.46. Over the past 10 years, this metric has ranged from a low of 2.61 to a high of 39.84. Based on the distribution chart, StemCell Institute ranks #278 out of 950 companies in the Biotechnology industry, which is above the industry midpoint. Overall, StemCell Institute has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does StemCell Institute's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, StemCell Institute ranks #278 out of 950 companies for OCF Margin %. This puts StemCell Institute in the upper half of its industry. Historically, StemCell Institute's own OCF Margin % has ranged from 2.61 to 39.84 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on StemCell Institute and its competitors. StemCell Institute's current OCF Margin % is 2.85%, which is 84% below median its own 10-year median of 17.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is StemCell Institute stock overvalued right now?
Based on GuruFocus' analysis, StemCell Institute (TSE:7096) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,813.29, compared to a current price of 円768.00 — trading 57.6% below its estimated fair value. The current OCF Margin % is 2.85%, which is 84% below median its 10-year median of 17.46. StemCell Institute's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For StemCell Institute (TSE:7096), the current OCF Margin % is 2.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is StemCell Institute (TSE:7096) Overvalued in 2026?
Based on GuruFocus' analysis, StemCell Institute stock appears to be undervalued.
The current stock price of 円768.00 is trading 57.6% below its estimated GF Value™ of 円1,813.29.
GuruFocus considers StemCell Institute to be Possible Value Trap.
Key valuation signals for TSE:7096:
OCF Margin %: 2.85% (84% below median its 10-year median of 17.46)
GF Value™: 円1,813.29 vs. price of 円768.00 (57.6% below fair value)
No single metric tells the full story. See the TSE:7096 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
StemCell Institute is engaged in the Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects the mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood. The Company operates in a single segment, the cell bank business sales consist of three components: technical fees, storage fees, and other fees.
69GF Score
Get the complete analysis for TSE:7096
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7096 has been successfully added to your 
